XML 22 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net income $ 20,405 $ 25,625 $ 27,122
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 15,342 15,989 14,663
Impairment charge     735
Deferred income taxes 12,528 15,664 17,585
Amortization of debt issuance costs 776 797 820
Amortization of syndication contracts 398 360 440
Payments on syndication contracts (388) (510) (578)
Non-cash stock-based compensation 5,035 5,240 4,351
(Gain) loss on debt extinguishment 161 204 246
Changes in assets and liabilities:      
(Increase) decrease in trade receivables 1,397 871 (6,128)
(Increase) decrease in prepaid expenses and other current assets 439 (499) (1,183)
Increase (decrease) in accounts payable, accrued expenses and other liabilities 1,203 (1,458) (3,661)
Net cash provided by operating activities 57,296 62,283 54,412
Cash flows from investing activities:      
Purchases of property and equipment and intangibles (9,053) (13,696) (8,609)
Purchase of a business, net of cash acquired     (15,048)
Purchases of short term investments: CDs (30,000)    
Proceeds from short term investments: CDs 30,000    
Purchases of investments (500)    
Net cash used in investing activities (9,553) (13,696) (23,657)
Cash flows from financing activities:      
Payments on long-term debt (23,750) (23,750) (23,750)
Dividends paid (11,177) (9,350) (8,865)
Repurchase of Class A common stock     (12,543)
Payment of contingent consideration   (1,000)  
Net cash used in financing activities (34,147) (31,923) (43,317)
Proceeds from stock option exercises, net 780 2,177 1,841
Net increase (decrease) in cash and cash equivalents 13,596 16,664 (12,562)
Cash and cash equivalents:      
Beginning 47,924 31,260 43,822
Ending 61,520 47,924 31,260
Cash payments for:      
Interest 14,693 12,249 15,265
Income taxes 593 750 859
Supplemental disclosures of non-cash investing and financing activities:      
Capital expenditures financed through accounts payable, accrued expenses and other liabilities $ 1,068 $ 813 $ 960